Nonmyeloablative allogeneic stem cell transplantation for chronic lymphocytic leukaemia offers the possibility of disease control with minimal morbidity and mortality—a single institution experience-Reference-Cited by-同舟云学术

Nonmyeloablative allogeneic stem cell transplantation for chronic lymphocytic leukaemia offers the possibility of disease control with minimal morbidity and mortality—a single institution experience

Published:2015-08-12 Issue:10 Volume:94 Page:1717-1725
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Chakupurakal G.^ORCID,Leitzke S.,Langerbeins P.,Schiller J.,Schneider P. M.,Holtick U.,Shimabukuro-Vornhagen A.,Theurich S.,Chemnitz J.,Hallek M.,von Bergwelt-Baildon M.,Scheid C.

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-015-2449-1.pdf

Reference23 articles.

1. Ghielmini M, Vitolo U, Kimby E et al (2013) ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL). Ann Oncol: J Eur Soc Med Oncology / ESMO 24(3):561–576. doi: 10.1093/annonc/mds517

2. Dreger P (2013) European Group for B, Marrow T. The evolving role of stem cell transplantation in chronic lymphocytic leukemia. Hematol/Oncol Clin North America 27(2):355–369. doi: 10.1016/j.hoc.2013.01.007

3. Dreger P, Corradini P, Kimby E et al (2007) Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus. Leukemia 21(1):12–17. doi: 10.1038/sj.leu.2404441

4. Schetelig J, van Biezen A, Brand R et al (2008) Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis. J Clin Oncol: Off J Am Soc Clin Oncol 26(31):5094–5100. doi: 10.1200/JCO.2008.16.2982

5. Herth I, Dietrich S, Benner A et al (2014) The impact of allogeneic stem cell transplantation on the natural course of poor-risk chronic lymphocytic leukemia as defined by the EBMT consensus criteria: a retrospective donor versus no donor comparison. Ann Oncol: Off J Eur Soc Med Oncol / ESMO 25(1):200–206. doi: 10.1093/annonc/mdt511

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age adjusted hematopoietic stem cell transplant comorbidity index predicts survival in a T-cell depleted cohort;Hematology/Oncology and Stem Cell Therapy;2018-06